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SUMMARY 
The ability of a number of commonly used inhibitors to inhibit 
pancreatic ribonuclease has been studied. At ribonuclease concen- 
trations of 10 or 100 g/ml, heparin, polyvinylsulfate and pro- 
teinase K, at concentrations reported for their use in the litera- 
ture, were ineffective in inhibiting RNase digestion of 3H-uridine 
labelled RNA from Streptomyces antibioticus. In contrast, macaloid, 
diethylpyrocarbonate and sodium dodecyl sulfate were all effective 
inhibitors, with the degree of effectiveness decreasing in the order 
stated. Further, at inhibitor concentrations which allowed RNase 
conversion of only 50% of the labelled RNA to acid soluble products, 
a larger percentage of the acid insoluble di estion products sedi- 
mented in the "high molecular weight" range 9 4-16s) when macaloid 
was the inhibitor used than when diethylpyrocarbonate was the inhi- 
bitor. 
In recent years, the increased interest in the properties of RNA's 
from prokaryotic and eukaryotic cells has accentuated the need for 
effective inhibitors of ribonuclease to use in RNA isolation. A number 
of presumed inhibitors have been used in various laboratories, inclu- 
ding sodium dodecyl sulfate (SDS, ref. 11, diethylpyrocarbonate (DEPC, 
refs. 2, 3), polyvinylsulfate (PVS, refs. 4, 5), heparin (HEP, refs. 
6, 7), macaloid (MAC, refs. 8, 9), and proteinase K (5, 10). These 
presumed inhibitors are frequently employed without any reference to 
their inhibitory ability and it is extremely difficult to determine 
the most effective inhibitor from the available literature. It was 
thus reasoned that the literature dealing with RNA isolation techni- 
ques would benefit from a direct comparison of these presumed inhibi- 
tors in terms of inhibitory activity. These studies are described 
below. 
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MATERIALS AND METHODS 
Materials - SDS was obtained from BDH Chemicals Ltd., DEPC and HEP 
(135 Units/mg) from Sigma, PVS from General Biochemicals, Macaloid 
from NL Industries and proteinase K from Merck. 
3 
H-labelled RNA was 
prepared by incubating 12 hr old cultures of Streptomyces antibioticus 
with 3H-uridine and extracting the RNA as previously described (11). 
Pancreatic RNase was from Calbiochem. 
Methods - Assays for RNase activity were performed in 0.1 ml reaction 
mixtures containing: Tris-HCl, pH 7.6, 10 umole; 'H-RNA, 1.93 A260 
units (equivalent to 6000 acid precipitable counts per minute); RNase, 
1 or 10 F.rg (10 or 100 pg/ml) and inhibitors as indicated in the legends 
to Figs. 1 and 2. In each experiment, the range of inhibitor concen- 
trations was chosen so as to encompass the concentrations used in pub- 
lished RNA isolation experiments. Assay tubes were incubated for 5 
min at 30°, when 10% trichloroacetic acid (TCA) was added to precipitate 
remaining RNA. RNA precipitates were collected on glass fibre filters 
which were dried and examined by liquid scintillation counting. Results 
in Fig. 1 are expressed as percentage of the original acid insoluble 
counts remaining in each assay tube. In the absence of inhibitor, 
each of the two RNase levels used was sufficient to completely solubi- 
lize the added RNA. 
In some experiments, 0.3 ml incubations were performed as des- 
cribed above, containing 10 pg/ml RNase, and either no inhibitor, DEPC 
(2.5%) or MAC (0.5 mg/ml). At the end of the incubation, the RNA 
remaining was extracted (ll), combined with 10 A260 units of Escherichia 
coli tRNA and precipitated with ethanol. RNA thus obtained was analyzed 
via sucrose gradient centrifugation as described previously (12). 
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- Abilities of various inhibitors to prevent solublization of 
&il!RN: by pancreatic RNase. Assay conditions were as described in 
Materials and Methods and inhibitors were present at the concentra- 
tions indicated. Results are expressed as the percentage of the add 
acid insoluble RNA remaining after the incubation. 
RESULTS 
The data of Fig. 1 depict the ability of five of the substances 
tested to inhibit pancreatic RNase present at 10 or 100 ug/ml. It 
can be seen that PVS and HEP were completely ineffective at RNase inhi- 
bition at the concentrations used. In experiments not shown, it was 
also observed that proteinase K was an ineffective inhibitor under the 
assay conditions employed here. In contrast, SDS, DEPC and MAC were 
all effective inhibitors at some concentration. At 100 ug/ml RNase, 
the presence of DEPC and MAC prevented the solubilization of about 
30% of the added RNA while SDS prevented the solubilization of about 
20% of the added RNA. At 10 pg/ml RNase, SDS, DEPC and MAC prevented 
solublization of 43, 49 and 67% of the added RNA, respectively. 
The data presented above suggested that DEPC and MAC were the most 
effective of the RNase inhibitors tested. However, the assay used mea- 
471 






$ O. !  
fPACTlON NUMBER 
Fig. 2. - Sucrose gradient analysis of the RNA remaining after incu- 
bation of 3H-RNA with 10 g/ml RNase in the presence or absence of 
OEPC or MAC. See text for details of the incubation and RNA extrac- 
tion. Gradients (5-201) were centrifuged for 13.5 hr at 36,000 rpm 
and were collected and assayed as described previously (12). Radio- 
activity values have been corrected for background and the direction 
of sedimentation is from right to left. The positions of 23s, 16s 
and 4s RNA's were determined using marker RNA prepared from E. coli 
cells and run on a parallel gradient. 
sured only the ability of each inhibitor to prevent conversion of the 
added RNA to an acid soluble form. It seemed possible that an in- 
hibitormight prevent complete solubilization of the added RNA, but still 
allow significant conversion of higher molecular weight RNA to lower 
molecular weight RNA which was still insoluble in 10% TCA. To examine 
this possibility, three large scale (0.3 ml) RNase assay mixtures were 
prepared as described in Materials and Methods containing no inhibitor, 
2.5% DEPC or 0.5 mg/ml MAC, respectively, and 10 pg/ml RNase. The 
RNA was extracted after the incubation and analyzed by sucrose gradient 
centrifugation as described in Fig. 2. In the incubations described, 
the concentrations of DEPC and MAC were chosen so as to produce about 
equal levels of protection against RNase, and in each case, about 50% 
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of the RNA was recovered as compared with the control. In addition, 
the recovery of TCA precipitable RNA from the sucrose gradients was 
quite similar for the incubations containing DEPC and MAC (3500 cpm 
and 3700 cpm, respectively). It is evident from Fig. 2 that, although 
both DEPC and MAC prevented complete solubilization of about 50% of 
the added RNA, much more of the high molecular weight RNA was converted 
to lower molecular weight RNA in the presence of DEPC than in the pre- 
sence of MAC. For example, if one calculates the percentage of the 
total RNA recovered in gradient fractions 1-13, one observes that 
only 5% of the RNA from the incubation containing DEPC sediments in 
this region. In contrast, 37% of the RNA from the incubation con- 
taining MAC is recovered in tubes 1-13. Thus, DEPC is somewhat less 
effective than MAC in preventing conversion of higher to lower mole- 
cular weight RNA by RNase. 
DISCUSSION 
In summary, the data presented indicate that SDS, DEPC and MAC 
are all capable of inhibiting RNase at appropriate concentrations. It 
should be noted, however, that under the assay conditions employed, 
the concentrations of each inhibitor required to produce maximal inhi- 
bition were higher than the concentrations commonly employed in RNA 
isolation experiments (1, 4, 9). This observation may lead to diffi- 
culties when SDS and DEPC are employed for RNA isolation, since high 
concentrations of SDS might necessitate repeated ethanol precipita- 
of the RNA for its removal, and since DEPC has been reported to react 
with RNA (13). Macaloid, on the other hand, is a relatively inert 
acidic clay, whose presence in isolation mixtures apparently does not 
interfere with the preparation of RNA. In addition, it seems possi- 
ble that MAC could be included as an RNase inhibitor in solutions of 
purified RNA, and could be removed by centrifugation prior to the use 
of the RNA in biological assays. Although they are soluble in aqueous 
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solutions, the properties of SDS and DEPC would require their being ab- 
sent from RNA solutions to be used in biological assays. These con- 
siderations, coupled with the observation that MAC is more effective 
than DEPC in preventing conversion of higher to lower molecular weight 
RNA (Fig. 2) would seem to make macaloid the inhibitor of choice in 
RNA isolation procedures. 
As regards the other presumed inhibitors tested, PVS, HEP and pro- 
teinase K, it may be argued that these substances would have been effec- 
tive at lower RNase concentrations. Indeed, it seems reasonable to 
conclude that the RNase concentrations used in these experiments were 
higher than one would expect to observe in cellular extracts. However, 
it is clear that even at this high RNase concentration, three of the 
six inhibitors tested are quite effective. It seems reasonable to 
conclude that the same relative activity would be manifested at lower 
RNase concentrations. 
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